Rebecca Haberman

Title: The Innovative Contributions of Rebecca Haberman

Introduction

Rebecca Haberman is a notable inventor based in Baltimore, MD (US). She has made significant strides in the field of cognitive function improvement, holding a total of 3 patents. Her work focuses on developing methods and compositions that address cognitive impairments associated with central nervous system disorders.

Latest Patents

Among her latest patents, one invention is titled "Methods and compositions for improving cognitive function." This invention specifically relates to treating cognitive impairment associated with central nervous system disorders. It emphasizes the use of inhibitors of synaptic vesicle glycoprotein 2A (SV2A), either alone or in combination with valproate, to treat cognitive impairment in subjects at risk for age-related cognitive decline. Another patent under her name also focuses on improving cognitive function in subjects exhibiting age-related cognitive impairment. This invention highlights the use of inhibitors of synaptic vesicle protein 2A (SV2A), such as levetiracetam, seletracetam, and brivaracetam, to enhance cognitive function in individuals at risk for Mild Cognitive Impairment (MCI), Age-related Cognitive Decline (ARCD), or Age-Associated Memory Impairment (AAMI).

Career Highlights

Rebecca Haberman is affiliated with The Johns Hopkins University, where she continues her research and innovation in cognitive health. Her contributions to the field have been recognized for their potential impact on improving the quality of life for individuals suffering from cognitive impairments.

Collaborations

She has collaborated with esteemed colleagues, including Michela Gallagher and Ming Teng Koh, to further advance her research initiatives.

Conclusion

Rebecca Haberman's innovative work in cognitive function improvement showcases her dedication to addressing significant health challenges. Her patents reflect a commitment to enhancing the lives of those affected by cognitive impairments.